A. Moody

Delays in managing lung cancer.

D. Forman, A. Moody, M. Muers, 2004, Thorax.

Tocilizumab for severe COVID-19 related illness – A community academic medical center experience

A. Moody, S. Katz, J. Meharg, 2020, Cytokine: X.

HITM-SURE: Hepatic immunotherapy for metastases phase Ib anti-CEA CAR-T study utilizing pressure enabled drug delivery

Kimberly R. Jordan, A. Moody, R. Schulick, 2020, Journal for ImmunoTherapy of Cancer.

Abstract CT109: HITM-SIR: Phase Ib trial of CAR-T hepatic artery infusions and selective internal radiation therapy for liver metastases

A. Moody, S. Katz, N. Espat, 2017 .

HITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA+ liver metastases

A. Moody, S. Katz, N. Espat, 2019, Cancer Gene Therapy.

Efforts to reduce delays in lung cancer management should not cease even though they may not affect the prognosis

D. Forman, A. Moody, M. Muers, 2011 .

HITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA+ liver metastases

A. Moody, N. Espat, E. Prince, 2019, Cancer Gene Therapy.